Nome |
# |
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?, file e3835328-e673-15e8-e053-a505fe0a3de9
|
540
|
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors, file e383531c-a011-15e8-e053-a505fe0a3de9
|
259
|
Comparative analysis of 2 commercial molecular tests for the detection of gastroenteric viruses on stool samples, file e3835323-b7ad-15e8-e053-a505fe0a3de9
|
232
|
Antiviral activity of fecal water samples from HIV-1 infected subjects treated with a specific probiotic formulation, file e3835323-a1e3-15e8-e053-a505fe0a3de9
|
224
|
SARS-CoV-2 presence in seminal fluid: myth or reality, file e3835326-0320-15e8-e053-a505fe0a3de9
|
194
|
Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors, file e383531e-9347-15e8-e053-a505fe0a3de9
|
176
|
Seroprevalence of group B Coxsackieviruses: retrospective study in an Italian population, file e3835326-634e-15e8-e053-a505fe0a3de9
|
168
|
Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting, file e383532e-15ff-15e8-e053-a505fe0a3de9
|
143
|
Redondovirus DNA in human respiratory samples, file e3835329-526c-15e8-e053-a505fe0a3de9
|
131
|
Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming, file e383531a-5f15-15e8-e053-a505fe0a3de9
|
126
|
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns, file e383531b-eaf0-15e8-e053-a505fe0a3de9
|
110
|
Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial, file e3835313-70c2-15e8-e053-a505fe0a3de9
|
108
|
Infectious agents in atherosclerotic cardiovascular diseases through oxidative stress, file e3835319-a86f-15e8-e053-a505fe0a3de9
|
98
|
SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period, file e3835329-454b-15e8-e053-a505fe0a3de9
|
97
|
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis, file e383532a-53d8-15e8-e053-a505fe0a3de9
|
88
|
COVID-19 in patients with hematologic disorders undergoing therapy: perspective of a large referral hematology center in Rome, file e3835328-7592-15e8-e053-a505fe0a3de9
|
87
|
MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients, file e3835313-6036-15e8-e053-a505fe0a3de9
|
84
|
Analysis of viral nucleic acids in duodenal biopsies from adult patients with active celiac disease: in search for an etiological relationship, file e3835328-8a89-15e8-e053-a505fe0a3de9
|
82
|
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia, file e3835326-2d59-15e8-e053-a505fe0a3de9
|
78
|
High HIV-1 diversity in immigrants
resident in Italy (2008–2017), file e3835324-df92-15e8-e053-a505fe0a3de9
|
76
|
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease, file e3835329-c1fc-15e8-e053-a505fe0a3de9
|
75
|
Infectious burden and atherosclerosis. A clinical issue, file e3835312-b918-15e8-e053-a505fe0a3de9
|
71
|
Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α, file e383532d-3828-15e8-e053-a505fe0a3de9
|
71
|
Molecular diagnosis of SARS-CoV-2 in seminal fluid, file e383532b-dbec-15e8-e053-a505fe0a3de9
|
69
|
Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2, file e383532d-3abf-15e8-e053-a505fe0a3de9
|
66
|
Anosmia and ageusia as predictive signs of COVID-19 in healthcare workers in Italy. A prospective case-control study, file e3835328-e20a-15e8-e053-a505fe0a3de9
|
65
|
TRANSMITTED DRUG RESISTANCE MUTATIONS AND TRENDS OF HIV-1 SUBTYPES IN TREATMENT-NAÏVE PATIENTS: A SINGLE CENTER EXPERIENCE, file e3835328-f6a2-15e8-e053-a505fe0a3de9
|
63
|
The role of teicoplanin in the treatment of SARS-CoV-2 infection: a retrospective study in critically ill COVID-19 patients (Tei-COVID Study), file e383532a-68a6-15e8-e053-a505fe0a3de9
|
60
|
The synergistic effect of time of exposure, distance and no use of personal protective equipment in the determination of SARS-CoV-2 infection: Results of a contact tracing follow-up study in healthcareworkers, file e383532d-3520-15e8-e053-a505fe0a3de9
|
55
|
Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab, file e3835325-c5e6-15e8-e053-a505fe0a3de9
|
53
|
KI and WU polyomavirus in respiratory samples of sars‐cov‐2 infected patients, file e383532c-6210-15e8-e053-a505fe0a3de9
|
52
|
Detection of SARS-CoV-2 RNA and antibodies in breast milk of infected mothers, file bef6a850-6418-4cbe-919b-6901fda7d791
|
50
|
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients, file e3835325-f56c-15e8-e053-a505fe0a3de9
|
49
|
SARS-CoV-2 infection: diagnostic testing results occasionally require special attention, file e3835329-9db2-15e8-e053-a505fe0a3de9
|
48
|
The role of teicoplanin in the treatment of SARS-CoV-2 infection: a retrospective study in critically ill COVID-19 patients (Tei-COVID Study), file e383532b-f3f8-15e8-e053-a505fe0a3de9
|
43
|
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies. Results from the HM-COV 2.0 study, file 7f3987f8-392d-4574-ab8b-2d0a786af5b5
|
42
|
Sperm cryopreservation during the SARS-CoV-2 pandemic, file e3835327-e57d-15e8-e053-a505fe0a3de9
|
40
|
Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab, file e383532c-84f1-15e8-e053-a505fe0a3de9
|
40
|
Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients, file 0c2ece4e-d40c-4003-949e-9f65e73b169c
|
33
|
Seroprevalence of group B Coxsackieviruses: retrospective study in an Italian population, file e3835326-f980-15e8-e053-a505fe0a3de9
|
30
|
Antiviral therapy: old and current issues., file e3835312-2f82-15e8-e053-a505fe0a3de9
|
26
|
Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome, file d019cefb-12c4-4f63-9c26-bc9a089fb7af
|
23
|
Alterations in the expression of IFN lambda, IFN gamma and toll-like receptors in severe COVID-19 patients, file a81cd31e-dc8d-4792-bda1-77a0c5e76ad5
|
21
|
Longitudinal virological and immunological profile in a case of human monkeypox infection, file 138569e3-bafc-4f69-bb23-72a358198918
|
20
|
Humoral and T-cell mediated response after administration of mRNA vaccine BNT162b2 in frail populations, file 17a2426b-c912-4b35-86b7-11e13cc8833b
|
20
|
Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients, file 9dd9cc24-7af3-4f59-85a5-4483922566e7
|
16
|
Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization, file e383531c-3486-15e8-e053-a505fe0a3de9
|
16
|
Prevalence of SARS-CoV-2 infection and associated risk factors. A testing program and nested case-control study conducted at Sapienza University of Rome between March and June 2021, file 19e72754-323a-4adc-836f-e69eb84700d7
|
15
|
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study, file 610a4b0b-dc98-48bd-b6bd-62eac1305aee
|
14
|
Systemic, mucosal immune activation and psycho-sexual health in art-suppressed women living with HIV. Evaluating biomarkers and environmental stimuli, file 742635c6-5035-4f2f-94fc-90e7efafb979
|
14
|
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report, file 61281648-2c18-473a-aa8a-2e40962c9780
|
13
|
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature, file e383532e-eb34-15e8-e053-a505fe0a3de9
|
12
|
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis, file e383532e-f594-15e8-e053-a505fe0a3de9
|
11
|
MicroRNA expression levels in peripheral blood mononuclear cells from human immunodeficiency virus type 1 positive individuals and relationship with different levels of viral suppression, file ca14dd22-7831-4215-95dd-dfce4a93caad
|
10
|
SARS-CoV-2 presence in seminal fluid: myth or reality, file e3835327-0c66-15e8-e053-a505fe0a3de9
|
10
|
siRNA transfection mediated by chitosan microparticles for the treatment of HIV-1 infection of human cell lines, file c199f4ae-477b-467f-8b85-9dc27e5f532a
|
9
|
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study., file e3835314-1350-15e8-e053-a505fe0a3de9
|
9
|
Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming, file e383531a-3acf-15e8-e053-a505fe0a3de9
|
8
|
CMV load quantitation by the automated VERSANT k-PCR Molecular System in plasma of transplanted patients, file e3835314-c1a3-15e8-e053-a505fe0a3de9
|
6
|
Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudine, file e3835312-0e84-15e8-e053-a505fe0a3de9
|
5
|
null, file e383531b-ea1c-15e8-e053-a505fe0a3de9
|
5
|
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients, file e3835323-a1e7-15e8-e053-a505fe0a3de9
|
5
|
The Many Faces of Immune Activation in HIV-1 Infection. A Multifactorial Interconnection, file d9fa0f0f-efd7-4ea4-8ce0-ee2ffddef075
|
4
|
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage regimen: 72-week follow-up, file e3835312-43a6-15e8-e053-a505fe0a3de9
|
4
|
Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients, file e3835316-ad58-15e8-e053-a505fe0a3de9
|
4
|
IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection, file e383531a-9865-15e8-e053-a505fe0a3de9
|
4
|
CRISPR/Cas9 ablation of integrated HIV-1 accumulates proviral DNA circles with reformed LTRs, file e383532d-54df-15e8-e053-a505fe0a3de9
|
4
|
Toll-like receptor 4-dependent platelet-related thrombosis in SARS-CoV-2 infection, file d677836c-b1be-49fc-b71e-6e6343267c90
|
3
|
Consolidation of molecular testing in clinical virology, file e3835316-c976-15e8-e053-a505fe0a3de9
|
3
|
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016, file e383531c-74db-15e8-e053-a505fe0a3de9
|
3
|
Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia, file e383531d-a63f-15e8-e053-a505fe0a3de9
|
3
|
Keeping university open did not increase the risk of SARS-CoV-2 acquisition: a test negative case-control study among students, file a9069cf6-3af3-4fb7-8a68-4ca4ee16516a
|
2
|
Potential benefit of dolutegravir once daily: Efficacy and safety, file e3835312-5b67-15e8-e053-a505fe0a3de9
|
2
|
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group, file e3835312-6f1b-15e8-e053-a505fe0a3de9
|
2
|
Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients, file e3835313-d76e-15e8-e053-a505fe0a3de9
|
2
|
Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment, file e383531a-143c-15e8-e053-a505fe0a3de9
|
2
|
Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients, file e3835320-6011-15e8-e053-a505fe0a3de9
|
2
|
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy, file e3835321-bd6b-15e8-e053-a505fe0a3de9
|
2
|
Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients, file e3835324-e8fc-15e8-e053-a505fe0a3de9
|
2
|
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19), file e3835329-4aac-15e8-e053-a505fe0a3de9
|
2
|
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition, file e383532e-9c58-15e8-e053-a505fe0a3de9
|
2
|
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose, file 895ad8e5-5864-47d3-83b0-623cec3edc2a
|
1
|
Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients, file e3835311-d2a9-15e8-e053-a505fe0a3de9
|
1
|
Short communication: analysis of the integrase gene from HIV type 1-positive patients living in a rural area of West Cameroon., file e3835311-dbed-15e8-e053-a505fe0a3de9
|
1
|
Early collection of saliva specimens from Bell's palsy patients: Quantitative analysis of HHV-6, HSV-1, and VZV, file e3835312-2aa3-15e8-e053-a505fe0a3de9
|
1
|
Pandemic 2009 H1N1 Influenza Virus Is Resistant to the Antiviral Activity of Several Interferon Alpha Subtypes, file e3835313-5969-15e8-e053-a505fe0a3de9
|
1
|
null, file e3835314-bf6e-15e8-e053-a505fe0a3de9
|
1
|
null, file e3835314-cb1c-15e8-e053-a505fe0a3de9
|
1
|
Sa1854 - Oral Bacteriotherapy Improves Gut Inflammation and Reduces Fecal Infectivity of HIV Subjects, file e3835322-1479-15e8-e053-a505fe0a3de9
|
1
|
Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success, file e3835323-8588-15e8-e053-a505fe0a3de9
|
1
|
Activation of latent HIV-1 T cell reservoirs with a combination of innate immune and epigenetic regulators, file e3835323-b7b0-15e8-e053-a505fe0a3de9
|
1
|
Copy-years viremia and risk of virological failure in long-term-treated HIV patients, file e3835324-b889-15e8-e053-a505fe0a3de9
|
1
|
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains, file e3835327-9f87-15e8-e053-a505fe0a3de9
|
1
|
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection, file e383532a-53c0-15e8-e053-a505fe0a3de9
|
1
|
Analysis of viral nucleic acids in duodenal biopsies from adult patients with active celiac disease: in search for an etiological relationship, file e383532b-7b1b-15e8-e053-a505fe0a3de9
|
1
|
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality, file e383532d-e9ec-15e8-e053-a505fe0a3de9
|
1
|
Totale |
4.531 |